Crystal Crop Protection IPO GMP Today: Grey Market Premium Falls to ₹15 Ahead of November 18 Launch
Crystal Crop Protection’s IPO is attracting investor attention ahead of its November 18 opening. The grey market premium has fallen to ₹15, indicating a potential listing gain of around 5.5% at...
Crystal Crop Protection’s IPO is attracting investor attention ahead of its November 18 opening. The grey market premium has fallen to ₹15, indicating a potential listing gain of around 5.5% at the upper end of the issue price band.
Table Of Content
The upcoming initial public offering (IPO) of Crystal Crop Protection is drawing attention from India’s primary market investors. As of November 16, 2026, the company’s shares were commanding a grey market premium (GMP) of approximately ₹15 per share.
At this premium, the indicative listing price works out to ₹287 against the upper issue price of ₹272. This represents a potential premium of around 5.5%.
However, the grey market premium is an unofficial indicator of investor sentiment and does not guarantee the actual listing price.
According to Moneycontrol, the ₹455.49 crore IPO will open for subscription on November 18 and close on November 20, 2026.
Crystal Crop Protection IPO GMP Today
The latest grey market premium suggests that investor expectations have moderated ahead of the public issue.
The GMP stood at approximately ₹45 on November 13 before declining to ₹27 on November 14 and ₹15 on November 16.
This fall indicates weaker unofficial market expectations compared with the previous week.
| Particulars | Details |
|---|---|
| Latest GMP | ₹15 |
| Price band | ₹259–₹272 |
| Indicative listing price | ₹287 |
| Indicative premium | 5.5% |
| IPO opening date | November 18 |
| IPO closing date | November 20 |
These estimates use the upper price band of ₹272 and the reported GMP of ₹15.
Crystal Crop Protection IPO: Issue Size and Lot Details
Crystal Crop Protection plans to raise approximately ₹455.49 crore through its public offering.
The issue includes a fresh share sale worth ₹354.77 crore and an offer for sale (OFS) of 37.03 lakh shares worth approximately ₹100.71 crore.
The price band has been fixed at ₹259–₹272 per equity share.
The minimum application size is 55 shares. At the upper price band, retail investors will need approximately ₹14,960 to apply for one lot.
The issue allocation includes 50% for qualified institutional buyers, 35% for retail individual investors and 15% for non-institutional investors.
What Will Crystal Crop Protection Do With IPO Proceeds?
The company plans to use part of the fresh issue proceeds to repay or prepay certain borrowings.
It has earmarked approximately ₹31.29 crore for repayment of its own borrowings and ₹2.21 crore for investment in its subsidiary, Saffire Crop Science, to support debt repayment.
The remaining proceeds are intended for inorganic growth opportunities, strategic initiatives and general corporate purposes.
The OFS proceeds will go to the existing shareholders selling their shares rather than the company.
What Does Crystal Crop Protection Do?
Established in 1994, Crystal Crop Protection operates in India’s agricultural solutions and crop protection industry.
Its portfolio includes herbicides, fungicides, insecticides, seeds and natural crop solutions. The company also operates across research and development, manufacturing and distribution.
Its business is connected to the agricultural sector, where demand for crop protection products and improved farming solutions plays an important role.
Should Investors Consider the IPO?
The declining GMP deserves attention, but it should not be the only factor influencing an investment decision.
Investors should examine the company’s revenue growth, profitability, debt levels, cash flows, valuation and competitive position before applying.
The company’s Red Herring Prospectus (RHP) is an important document for understanding its financial performance and investment risks.
The Bottom Line
Crystal Crop Protection’s IPO enters the market with a ₹455.49 crore issue size and a grey market premium of ₹15 as of November 16.
While the indicative premium suggests positive listing expectations, the recent decline in GMP highlights changing market sentiment. Investors should focus on the company’s fundamentals rather than relying on unofficial grey market estimates.



No Comment! Be the first one.